Ozempic vs. Compounded Semaglutide: Understanding the Differences for Weight Management

Medical Disclaimer: The information provided in this article is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for personalized medical guidance, diagnosis, and treatment. Fig Health does not endorse self-medication or treatment without professional supervision.

For individuals exploring options for weight management, GLP-1 receptor agonists like semaglutide have emerged as significant advancements. You may have encountered two main forms: Ozempic (a brand-name semaglutide product) and compounded semaglutide. While both contain semaglutide, there are crucial differences in their regulatory status, composition, and oversight that patients should understand.

If you're considering GLP-1 medications for weight loss, start your journey with a healthcare professional. Begin your online visit with Fig Health today.

What is Ozempic?

Ozempic is an FDA-approved prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2017 for the treatment of type 2 diabetes to improve blood sugar control and reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1]. While Ozempic contains semaglutide, it is not FDA-approved for weight loss. Another brand-name semaglutide product, Wegovy, is specifically FDA-approved for chronic weight management.

Ozempic is manufactured under strict FDA regulations, ensuring its safety, efficacy, and consistent quality. Its formulation and dosage are standardized and rigorously tested through extensive clinical trials.

What is Compounded Semaglutide?

Compounded semaglutide refers to medications prepared by a compounding pharmacy for an individual patient based on a prescription from a licensed healthcare provider. Compounding pharmacies can create customized medications when an FDA-approved drug is not commercially available or when a patient has specific needs (e.g., allergies to inactive ingredients in the commercial product) that cannot be met by the approved version [2].

It is critical to understand that compounded semaglutide is not FDA-approved [3]. This means that compounded versions have not undergone the same rigorous review process for safety, effectiveness, and quality that FDA-approved drugs like Ozempic and Wegovy have. The FDA does not verify the purity, potency, or consistency of compounded drugs before they are marketed [2].

Key Differences: Ozempic vs. Compounded Semaglutide

The distinctions between brand-name, FDA-approved semaglutide products and compounded semaglutide are significant and can impact patient safety and treatment outcomes.

Feature Ozempic (Brand-Name Semaglutide) Compounded Semaglutide FDA Approval Yes, fully FDA-approved for specific indications [1]. No, not FDA-approved [3]. Regulatory Oversight Strict FDA manufacturing and quality control standards. Less stringent oversight; regulated by state boards of pharmacy [2]. Composition Standardized, tested formulation. May vary in ingredients, purity, and potency. Some compounded products have been found to use salt forms of semaglutide (e.g., semaglutide sodium or acetate), which are different active ingredients from those in approved drugs and lack established safety and efficacy data [2]. Safety & Efficacy Proven through extensive clinical trials (e.g., STEP trials for weight management with Wegovy) [4]. Not evaluated for safety or efficacy by the FDA. Potential for adverse events due to dosing errors or unknown impurities [2]. Availability Subject to manufacturer supply and shortages. Available when FDA-approved versions are in shortage or for specific patient needs [2].

FDA Concerns Regarding Compounded GLP-1 Medications

The FDA has issued warnings regarding compounded GLP-1 drugs, highlighting several concerns [2]:

Lack of Safety and Efficacy Review: Compounded drugs do not undergo FDA review for safety, effectiveness, or quality before being marketed.
Use of Different Active Ingredients: Some compounded semaglutide products have been found to contain salt forms of semaglutide (e.g., semaglutide sodium or semaglutide acetate). These are different active ingredients from the semaglutide used in FDA-approved products, and their safety and efficacy are not established [2].
Dosing Errors: The FDA has received reports of adverse events, including hospitalizations, related to dosing errors with compounded injectable semaglutide products. These errors can stem from patients or healthcare professionals miscalculating doses [2].
Quality Issues: Concerns exist regarding improper storage during shipping, which can affect drug quality, and instances of fraudulent compounded products with false labeling [2].

Fig Health's Approach to GLP-1 Medications

Fig Health is committed to providing access to medically sound and transparent weight management solutions. We understand the complexities of navigating GLP-1 options and prioritize patient safety and clear information.

Fig Health offers access to compounded semaglutide and tirzepatide through our network of licensed compounding pharmacies when medically appropriate and in compliance with state and federal regulations. Our transparent pricing model ensures you know the costs upfront:

Semaglutide: $145-$175 per month
Tirzepatide: $233-$279 per month
Membership Fee: $0

We believe in empowering patients with knowledge and access to care from qualified healthcare professionals who can assess individual needs and prescribe the most suitable treatment plan.

Conclusion

Choosing between brand-name Ozempic (or other FDA-approved semaglutide products like Wegovy) and compounded semaglutide requires careful consideration of their fundamental differences. While brand-name products offer the assurance of FDA approval and rigorous testing, compounded versions can serve a vital role when FDA-approved options are unavailable or unsuitable for specific patient needs, provided they are obtained from reputable sources under strict medical supervision.

Always consult with a healthcare professional to determine the best course of action for your weight management journey. They can provide personalized advice based on your health history and treatment goals.

Ready to explore your weight management options with expert guidance? Start your confidential online visit with Fig Health today.

References

[1] U.S. Food and Drug Administration. (2023). OZEMPIC (semaglutide) injection Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf

[2] U.S. Food and Drug Administration. (2026, June 15). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Retrieved from https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

[3] Novo Nordisk. (n.d.). Compounded "semaglutide" is not FDA-approved. Retrieved from https://www.novomedlink.com/semaglutide/patient-safety/difference-fda-approved-compounded-semaglutide.html

[4] Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183